Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1073
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4148    
    Printed154    
    Emailed0    
    PDF Downloaded291    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2010  |  Volume : 47  |  Issue : 4  |  Page : 412-417

Detection of B cell lymphoma 2, tumor protein 53, and FAS gene transcripts in blood cells of patients with breast cancer


1 Cancer Gene Therapy Laboratory, Shiraz Institute for Cancer Research, Shiraz, Iran
2 Immunotherapy Laboratory, Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
3 Cancer Gene Therapy Laboratory, Shiraz Institute for Cancer Research; Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
4 Cancer Gene Therapy Laboratory, Shiraz Institute for Cancer Research; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran

Correspondence Address:
M Habibagahi
Immunotherapy Laboratory, Department of Immunology, Shiraz University of Medical Sciences, Shiraz
Iran
Login to access the Email id

Source of Support: Iranian Cancer Network, Shiraz Institute and Shiraz University of Medical Sciences, Conflict of Interest: None


DOI: 10.4103/0019-509X.73576

Rights and Permissions

Background: Proteins encoded by FAS, BCL-2 and TP53 genes are major regulators of cellular survival and apoptosis. Results of recent investigations show remarkable biological features of these factors, which propose their role in the course of cancer. Therefore, it is plausible to test whether transcripts of these genes could be detected in the peripheral blood cells of patients with breast cancer. Materials and Methods: Real-time polymerase chain reaction assay was performed to detect FAS, BCL-2, and TP53 gene transcripts in the peripheral blood samples of 50 women with histologically confirmed infiltrative ductal carcinoma of the breast. Gene expression of patients was compared with 40 healthy women without history of malignancies or autoimmune disorders. Results: The relative overexpression of BCL-2 in the blood cells from patients of early stages (I and II), nonmetastatic and low-grade tumors compared with healthy individuals, was shown by measuring the gene transcript. Similarly, 3-4-fold higher expression of FAS was found in those patients. The measurement of TP53 transcripts also showed higher levels of gene expression in patients compared with healthy controls. BCL-2 gene expression showed a significant correlation with FAS, while such a correlation was not observed between BCL-2 and TP53 . Conclusion: It seems tumor cells overexpress BCL-2 to inhibit apoptosis and guarantee their cell survival. As a physiologic response, FAS and TP53 could be upregulated to suppress tumors. However, these pathways at early stages of disease may be inadequate and cause progressive malignancy.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow